Papadaki, C.; Manolakou, S.; Lagoudaki, E.; Pontikakis, S.; Ierodiakonou, D.; Vogiatzoglou, K.; Messaritakis, I.; Trypaki, M.; Giannikaki, L.; Sfakianaki, M.;
et al. Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study. Cancers 2020, 12, 1013.
https://doi.org/10.3390/cancers12041013
AMA Style
Papadaki C, Manolakou S, Lagoudaki E, Pontikakis S, Ierodiakonou D, Vogiatzoglou K, Messaritakis I, Trypaki M, Giannikaki L, Sfakianaki M,
et al. Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study. Cancers. 2020; 12(4):1013.
https://doi.org/10.3390/cancers12041013
Chicago/Turabian Style
Papadaki, Chara, Stavroula Manolakou, Eleni Lagoudaki, Spyros Pontikakis, Despo Ierodiakonou, Konstantinos Vogiatzoglou, Ippokratis Messaritakis, Maria Trypaki, Linda Giannikaki, Maria Sfakianaki,
and et al. 2020. "Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study" Cancers 12, no. 4: 1013.
https://doi.org/10.3390/cancers12041013
APA Style
Papadaki, C., Manolakou, S., Lagoudaki, E., Pontikakis, S., Ierodiakonou, D., Vogiatzoglou, K., Messaritakis, I., Trypaki, M., Giannikaki, L., Sfakianaki, M., Kalykaki, A., Mavroudis, D., Tzardi, M., & Souglakos, J.
(2020). Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study. Cancers, 12(4), 1013.
https://doi.org/10.3390/cancers12041013
